Changchun High & New Technology Industries Group Inc (000661.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE0000007J8

Price
68.74 CNY
Market cap
28.04 bn CNY
P/E (2025)
180.95
P/S (2025)
2.32
Dividend yield
0.23 %
Net margin
1.28 %
Return on equity (ROE)
0.62 %
Return on assets (ROA)
0.52 %

Changchun High & New Technology Industries Group Inc financials

Fiscal year20242025
Revenue13.47 bn CNY12.08 bn CNY
Gross profit11.39 bn CNY9.92 bn CNY
Operating income3.30 bn CNY870.26 m CNY
EBIT3.50 bn CNY43.73 m CNY
Net income2.58 bn CNY154.97 m CNY
Diluted EPS – continuing operations6.42 CNY0.38 CNY

Full history since 1993, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Changchun High & New Technology Industries Group Inc

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet. It also develops real estate properties. The company was founded in 1993 and is based in Changchun, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.